Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
07/2000
07/12/2000EP1017664A1 C3a receptor ligands
07/12/2000EP0788486B1 Herbicidal sulfonyl urea derivatives
07/12/2000EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies
07/12/2000CN1054377C New bicyclic derivatives of imidazole and their prepn. process, their use as medicaments and the pharmaceutical compositions containing them
07/12/2000CN1054372C Amino substituted benzosulfonylurea and -thiorea prepn. and pharmaceutical use of same
07/11/2000US6087530 Process for preparing β-amino-α-hydroxy acid derivatives
07/11/2000US6087399 Sulfonamide-substituted compounds, process for their preparation, their use as a medicament or diagnostic, and a medicament comprising them
07/11/2000US6087304 Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
07/06/2000WO2000039088A1 Glucagon antagonists/inverse agonists
07/06/2000WO2000039077A2 Thyroid receptor ligands
07/06/2000WO2000038813A1 Dehydration process
07/06/2000WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS
07/06/2000CA2356319A1 Thyroid receptor ligands
07/06/2000CA2353480A1 Dehydration process
07/05/2000EP1016916A1 Photographic element containing high dye-yield couplers
07/05/2000EP1016646A1 Intermediates for the preparation of cephalosporines containing on the 7-position a substituted benzyloximino radical
07/05/2000EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments
07/05/2000EP1015417A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
07/05/2000EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
07/05/2000EP1014962A1 Antithrombotic agents
07/05/2000CN1259121A Novel sulfonamide derivatives
07/05/2000CN1259120A Calcilytic compounds
07/05/2000CN1258861A Photographic element containing high dye productivity colour former
07/04/2000US6084130 For treatment of central nervous system disorders
07/04/2000US6083987 Phenylenediamine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
07/04/2000US6083986 Amine derivative substituted indane compound useful for the treatment of cardiac arrhythmias and cell proliferative disorders
07/04/2000US6083981 Sulfonamide substituted aspartic acid interleukin-1β converting enzyme inhibitors
07/04/2000US6083977 Trienoic retinoid compounds and methods
07/04/2000CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents
06/2000
06/29/2000WO2000038013A1 Photographic couplers having improved image dye light stability
06/29/2000WO2000037633A1 Rna polymerase transcription promoters and method for determining base sequence
06/29/2000WO2000037436A1 Sulfonamide hydroxamates
06/29/2000WO2000037433A1 Inhibitors of matrix metalloproteinases
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000CA2355902A1 Sulfonamide hydroxamates
06/29/2000CA2321187A1 Rna polymerase transcription promoters and method for determining base sequence
06/28/2000EP1014186A1 Photographic yellow dye-forming couplers
06/28/2000EP1013658A1 Aminophosphine-metal complex for asymmetric reactions
06/28/2000EP1011652A1 Novel diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus
06/28/2000CN1053899C Acylguanidine, its preparation process and use, and pharmaceutical composition contg. same
06/28/2000CN1053893C Process for manufacture of dicarboxamides
06/27/2000US6080869 Chemical reduction process; forming dopamine da2 receptor agonists and beta2 adrenoreceptor agonists for treating obstructive airways diseases
06/27/2000US6080587 Method for preparing and selecting pharmaceutically useful sulfur-bridged bi- and triaromatic ring compounds from a structurally diverse universal library
06/22/2000WO2000035882A1 1,2,3,4-tetrahydronaphthalenes and their pharmaceutical use
06/22/2000WO2000035865A2 Tubulin-binding agents
06/22/2000WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000WO2000035679A1 Heat sensitive recording material
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355161A1 Biphenyl and biphenyl-analogous compounds as integrin antagonists
06/21/2000EP1011015A1 Silver halide photographic light sensitive material and hydrazine compound employed in it
06/21/2000EP1010691A2 Hydrazide derivatives, process for their preparation and pharmaceutical compositions containing them
06/21/2000EP1009743A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
06/21/2000EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
06/21/2000CN1257474A New nitromethyl ketones, process for preparing them and compositions containing them
06/20/2000US6077854 Tri-substituted phenyl derivatives and processes for their preparation
06/17/2000CA2292246A1 New hydrazide derivatives, the procedure for preparing them and the pharmaceutical formulations that contain them
06/15/2000WO2000034234A1 Aryl- and heteroarylamides of carboalkoxysulfanilic acids
06/15/2000CA2357803A1 Aryl- and heteroarylamides of carboalkoxysulfanilic acids
06/14/2000EP1008592A2 Cyclic amide derivatives which inhibit cathepsin K
06/14/2000EP1008342A2 Pharmaceutically active compounds and liposomes, and methods of use thereof
06/14/2000EP1007509A2 Antimicrobial compounds
06/14/2000EP0777645B1 Oxime ethers and their use as pesticides
06/13/2000US6075166 Solid phase synthesis of amines; as a sequential encoding, or a tagging agent
06/13/2000US6075130 Calixarene containing upper rim and a lower rim, atleast one ionizable group attached to lower rim and a radionuclide ion from lantahnide elements bound to ionizable group
06/08/2000WO2000032570A1 Hydrazine derivatives
06/08/2000WO2000032569A2 Alpha-sulfin- and alpha-sulfonamino acid amides
06/08/2000WO2000032568A2 $g(a)-sulfin- and $g(a)-sulfonamino acid amides
06/08/2000WO2000032560A1 Novel compound, polymer prepared from the compound, and composition comprising the polymer
06/08/2000WO2000032552A1 Process for the preparation of functionalized chiral cyclopentanes involving transformation of azanorbornyl derivatives
06/08/2000CA2351321A1 Hydrazine derivatives
06/07/2000EP1005453A1 Substituted benzene compounds as antiproliferative and cholesterol lowering agents
06/07/2000EP1005448A2 Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
06/07/2000EP1005445A1 N-alkanoylphenylalanine derivatives
06/07/2000CN1053210C Products comprising base materials treated by surface fluoroaliphatic compound
06/06/2000US6072075 Trisubstituted n-protected guanidines
06/06/2000US6071683 Image dye-forming couplers and photographic elements containing them
06/06/2000US6071510 Modified amino acids and compositions comprising the same for delivering active agents
06/02/2000WO2000031046A1 Novel acylguanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
06/02/2000WO2000031044A1 Iminoguanidine derivatives, preparation method, use as medicines
06/02/2000WO2000031022A1 Amphiphilic polyamine compounds
06/02/2000WO2000031021A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
06/02/2000CA2352279A1 Amphiphilic polyamine compounds
06/02/2000CA2351692A1 Inhibitors of production and/or secretion of amyloid-.beta. protein
05/2000
05/31/2000EP1004573A1 Aryloxyaniline derivatives
05/31/2000EP1003720A1 Aryloxyarylsulfonylamino hydroxamic acid derivatives
05/31/2000EP1003719A2 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives
05/31/2000EP1003718A1 Method for the production of n-(5-amino-2-cyano-4-fluoro-phenyl)-sulphonamides and new intermediate products
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP1003495A1 Pharmaceutical compounds
05/31/2000EP1003492A2 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins
05/31/2000EP0858448B1 N-sulphonyl and n-sulphinyl amino acid derivatives as microbicides
05/31/2000EP0794942B1 Substituted biphenyl compounds for the treatment of inflammation
05/31/2000CN1255119A Protease inhibitors
05/31/2000CN1255117A Excitatory amino acid receptor modulators
05/31/2000CN1052976C Substituted benzenesulfonylureas and -thioureas, preparation process and possible uses of pharmaceutical preparation therefor
05/30/2000US6069130 Prodrugs useful in vivo or invitro for preventing or treating coagulation disorders
05/30/2000CA1341010C Compounds useful in preparing fluorine-containing chiral smectic liquid crystals
05/25/2000WO2000029399A1 Antiherpes compounds
05/24/2000EP1001931A1 Process for preparing perfluoroalkane-1-sulfonyl (perfluoroalkylsulfonyl) imide-n-sulfonyl- containing methanides, imides and sulfonates, and perfluoroalkane-1-n- sulfonylbis(perfluoroalkylsulfonyl) methanides